Skip to main content
eScholarship
Open Access Publications from the University of California

Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infections have grown to epidemic proportions in the United States. With the development of increasing drug resistance of MRSA to traditional antimicrobials, there has been a search for a more effective antibiotic treatment. Linezolid is one of the most effective oral medications used for outpatient treatment of MRSA infections. We present a case of pancytopenia after outpatient treatment with linezolid. Myelosuppression is a rare but serious side effect of linezolid of which emergency physicians need to be aware in order to provide early intervention.

[WestJEM. 2008;9:177-178.]

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View